Combining evidence for and against pathogenicity for variants in cancer susceptibility genes: CanVIG-UK consensus recommendations
Alice Garrett(Institute of Cancer Research), Clare Turnbull(Royal Marsden NHS Foundation Trust), James Drummond(Cambridge University Hospitals NHS Foundation Trust), Rachel Robinson(Leeds Teaching Hospitals NHS Trust), Bethany Torr(Institute of Cancer Research), Marc Tischkowitz(University of Cambridge), Alison Callaway(Wessex Regional Genetics Laboratory), George J. Burghel, Andrew J. Wallace, Miranda Durkie(Sheffield Children's NHS Foundation Trust), Cankut Çubuk(Queen Mary University of London), Sian Ellard(University of Exeter), Ian Berry(Leeds Teaching Hospitals NHS Trust), Diana Eccles(Princess Anne Hospital), Helen Hanson(University of Exeter)
Cited by 63
Related Papers
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
|Nature Genetics|2013|1.1k
MicroRNA Related Polymorphisms and Breast Cancer Risk
|PLoS ONE|2014|638
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer
|Nature Genetics|2015|634
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2
|Nature Genetics|2009|484